1
/
of
0
FDA Summary Basis of Approval – Labeling Information for Glatiramer Acetate Injection, 40 mg/mL (Application A206873, Approved September 25, 2024)
FDA Summary Basis of Approval – Labeling Information for Glatiramer Acetate Injection, 40 mg/mL (Application A206873, Approved September 25, 2024)
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request Contents: Summary Basis of Approval – Labeling Information for Glatiramer Acetate Injection, 40 mg/mL, Application A206873, approved September 25, 2024
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details